Back to Reference Library
veterinary
behaviour
farriery
2006
Expert Opinion

Cytokine gene signatures in neural tissue of horses with equine protozoal myeloencephalitis or equine herpes type 1 myeloencephalopathy.

Authors: Pusterla N, Wilson W D, Conrad P A, Barr B C, Ferraro G L, Daft B M, Leutenegger C M

Journal: The Veterinary record

Summary

# Editorial Summary Researchers used real-time PCR to quantify pathogen-specific and immune gene expression in post-mortem neural tissue from horses with equine protozoal myeloencephalitis (EPM; *n*=12), equine herpesvirus type 1 myeloencephalopathy (EHV-1; *n*=11), and healthy controls (*n*=12), examining transcription of *Sarcocystis neurona*, *Neospora hughesi*, EHV-1, and eight cytokine markers. *S. neurona* was detected in all EPM cases (mean relative transcription 123-fold baseline; range 1–461-fold), with two horses also harbouring *N. hughesi* cDNA, whilst all EHV-1 cases showed positive viral signals (mean 275-fold; range 1–1618-fold), and no pathogens were detected in controls. The cytokine signatures differed meaningfully between diseases: EPM cases exhibited a predominantly pro-inflammatory Th1 response with consistent IL-8, TNF-α and IFN-γ expression but absent or minimal Th2 markers (IL-4, IL-6, IL-10), whereas EHV-1 cases showed IL-8 upregulation without reciprocal IFN-γ or IL-10 expression and minimal TNF-α. These distinct immune profiles suggest fundamentally different pathogenic mechanisms and may eventually help clinicians differentiate between these clinically similar myeloencephalopathies; the pro-inflammatory bias in EPM particularly warrants investigation of whether targeted anti-inflammatory strategies could mitigate neurological damage alongside conventional antimicrobial therapy.

Read the full abstract on PubMed

Practical Takeaways

  • The distinct cytokine gene expression patterns between EPM and EHV-1 myeloencephalopathy offer potential molecular diagnostic markers to differentiate these neurological diseases in field cases
  • Pro-inflammatory Th1 dominance in EPM suggests targeted immune modulation strategies may warrant investigation as adjunctive therapeutic approaches
  • Real-time PCR analysis of neural tissue cytokine profiles could improve diagnostic accuracy when clinical presentation is ambiguous between these two conditions

Key Findings

  • Sarcocystis neurona cDNA detected in neural tissue of all 12 EPM-affected horses with transcription levels ranging 1-461 times baseline (mean 123)
  • All 11 EHV-1 myeloencephalopathy horses showed positive viral signals with transcription levels 1-1618 times baseline (mean 275)
  • EPM cases showed Th1 pro-inflammatory cytokine profile (IL-8, TNF-alpha, IFN-gamma commonly expressed) with absent or rare Th2 anti-inflammatory response
  • EHV-1 cases displayed IL-8 expression with absent IFN-gamma and rare TNF-alpha, differing from EPM cytokine signature

Conditions Studied

equine protozoal myeloencephalitis (epm)equine herpesvirus type 1 (ehv-1) myeloencephalopathy